Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals Inc Cl A (NQ: RXRX )

7.325 -0.025 (-0.34%)
Streaming Delayed Price Updated: 3:30 PM EDT, Jul 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,539,078
Open 7.360
Bid (Size) 7.320 (19)
Ask (Size) 7.330 (6)
Prev. Close 7.350
Today's Range 7.210 - 7.405
52wk Range 4.970 - 16.75
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Stocks This Amazon-Backed AI Says Will Turn $1K into $1M by 2030
These high-risk, high-reward stocks have the potential to turn $1K into $1M by 2030, according to Amazon-backed AI Claude 3.5 Sonnet. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Cathie Wood's Ark Invest Sells Tesla Shares Worth $14.5M Amid Rally Driven By Q2 Delivery Numbers, Picks Up Palantir Shares Again Today
Via Benzinga

Performance

YTD
-25.79%
-25.79%
1 Month
-12.90%
-12.90%
3 Month
-16.09%
-16.09%
6 Month
-34.07%
-34.07%
1 Year
+0.48%
+0.48%

More News

Read More
Cathie Wood-Led Ark Invest Scoops Up $5.16M Worth Of Palantir Shares Amid Raging AI Fervor
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet
Via InvestorPlace
Why Recursion Pharmaceuticals Stock Is Tumbling Thursday
Via Benzinga
Levi Strauss Posts Mixed Results, Joins Walgreens, AeroVironment And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
3 AI Stocks on the Edge of a Massive Surge
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Recursion Announces Pricing of $200 Million Public Offering of Class A Common Stock
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion Pharmaceuticals Stock Is Diving Wednesday: What's Going On?
Via Benzinga
Recursion Announces Proposed Offering of Class A Common Stock
From Recursion Pharmaceuticals
Via GlobeNewswire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Recursion Pharmaceuticals Stock Is Moving Tuesday: What's Happening?
Via Benzinga
What's Going On With Recursion Pharmaceuticals Stock Monday?
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Recursion Gives Guidance on Seven Clinical Readouts within ~18 Months and Partnership Updates at Their Download Day
From Recursion Pharmaceuticals, Inc.
Via GlobeNewswire
Largest Clinical-Stage BioTech Drug Stocks Declined 6%
Via Talk Markets
NextEra Energy, Lennar And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th
Via Talk Markets
3 Stocks Under $10 Set to Quadruple by 2025: June Edition
Via InvestorPlace
AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week
Via Talk Markets
Recursion Pharmaceuticals Stock Could Be a 10-Bagger, but Only if It Comes Through on This Big Claim
Via The Motley Fool
Nvidia’s Golden Handshake: 3 Stocks Reaping the Rewards of an NVDA Alliance
Via InvestorPlace
1 Disruptive Biotech Stock to Buy Now, and 1 to Consider
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.